Investigational Medications in the Treatment of Alopecia

April 2005 in “ Expert Opinion on Investigational Drugs ”

Georgann Anetakis Poulos, Paradi Mirmirani

androgenetic alopecia chemotherapy-induced alopecia androgens minoxidil finasteride Namindil fluridil PSK-3841 LGD-1331 antiandrogen ODNs steroid sulfatase inhibitors KF19418 thymosin ß4 AGA Rogaine Propecia

TLDR New treatments for hair loss are being developed using molecular biology.

This document from 18 years ago discusses investigational medications for the treatment of alopecia, including androgenetic alopecia (AGA) and chemotherapy-induced alopecia. The article explains the pathogenesis of hair growth and how androgens are the most important hormone known to regulate hair growth. Currently, there are only two treatments approved by the US FDA for the treatment of AGA: minoxidil topical solution and finasteride. The article concludes by stating that advances in molecular biology are paving the way for a very exciting era of new therapeutics for hair disorders. The document provides expert opinions on various targeted treatments for androgenetic and chemotherapy-induced alopecia, including Namindil, fluridil, PSK-3841, LGD-1331, antiandrogen ODNs, steroid sulfatase inhibitors, KF19418, and thymosin ß4.

View this study on tandfonline.com →

Discuss this study in the Community →

Cited in this study

15 / 15 results

research Hair Growth Induction by the Tellurium Immunomodulator AS101: Association with Delayed Terminal Differentiation of Follicular Keratinocytes and Ras-Dependent Up-Regulation of KGF Expression

51 citations , December 2003 in “The FASEB Journal”

The substance AS101 can help hair grow by slowing down hair cell aging and boosting a hair growth protein.

research Thymosin Beta 4 Increases Hair Growth by Activation of Hair Follicle Stem Cells

98 citations , December 2003 in “The FASEB Journal”

Thymosin β4 promotes hair growth by activating stem cells in hair follicles.

research Guidelines for the Management of Alopecia Areata

182 citations , October 2003 in “British Journal of Dermatology”

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

research Effect of Adenovirus-Mediated Expression of Sonic Hedgehog Gene on Hair Regrowth in Mice With Chemotherapy-Induced Alopecia

39 citations , December 2001 in “JNCI: Journal of the National Cancer Institute”

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

research The psychology of hair loss and its implications for patient care

138 citations , March 2001 in “Clinics in Dermatology”

Hair loss can significantly affect a person's self-esteem and body image, especially in young people, those who value their looks highly, and women.

research Current and Potential Agents for the Treatment of Alopecia Areata>

41 citations , February 2001 in “Current pharmaceutical design”

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

research Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex

124 citations , April 2000 in “Nature biotechnology”

research Treatment of Hair Loss

370 citations , September 1999 in “The New England Journal of Medicine”

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

research Mucocutaneous reactions to chemotherapy

275 citations , March 1999 in “Journal of The American Academy of Dermatology”

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

research Finasteride is the main inhibitor of 5α-reductase activity in microdissected dermal papillae of human hair follicles

28 citations , February 1999 in “Archives of Dermatological Research”

Finasteride potentially treats hair loss by reducing DHT production.

research Evaluation of RU58841 as an Anti-Androgen in Prostate PC3 Cells and a Topical Anti-Alopecia Agent in the Bald Scalp of Stumptailed Macaques

18 citations , January 1998 in “Endocrine”

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

research A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice

9 citations , November 1997 in “British Journal of Dermatology”

research A randomized trial of minoxidil in chemotherapy-induced alopecia

127 citations , July 1996 in “Journal of The American Academy of Dermatology”

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

research Finasteride

187 citations , January 1994 in “The New England Journal of Medicine”

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

research RU 58841, a new specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism

49 citations , January 1994 in “The Journal of Steroid Biochemistry and Molecular Biology”

RU 58841 may treat acne, hair loss, and excessive hair growth.

3 / 3 results

research Body to Scalp: Evolving Trends in Body Hair Transplantation

22 citations , January 2017 in “Indian Dermatology Online Journal”

Body hair transplants can treat baldness but differ from scalp hair and need more research on long-term results and side effects.

research Disorders of Hair

July 2013 in “DeckerMed Medicine”

The document's conclusion cannot be provided because the document is not readable or understandable.

research Towards a molecular understanding of hair loss and its treatment

236 citations , July 2001 in “Trends in Molecular Medicine”

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.